Particle.news
Download on the App Store

Kendra Wilkinson Credits Effecty After Dropping Several Dress Sizes on GLP-1 Regimen

Sponsored social posts from the three-month update put celebrity marketing of GLP-1 drugs at the center of questions about self-reported results and medical context.

Overview

  • Late July posts and a sponsored video show Wilkinson saying she is three months into a GLP-1 program with Effecty and that her clothes have gone from about a size 10 to under a size 6.
  • Wilkinson says she measures progress by how her clothes fit and that she has not been weighing herself, so the changes are self-reported rather than clinically verified.
  • She began the regimen in March after signing up with a shot-delivery service, and she has publicly discussed the program on Instagram while offering an upcoming ad tied to the product.
  • Wilkinson frames the goal as finding 'balance' rather than extreme slimming and also posted about a recent professional setback and emotional struggles during the same period.
  • Journalists note GLP-1 drugs are approved for type 2 diabetes but have become a high-profile weight-loss option, and celebrity promotions could affect public demand and prompt further scrutiny of medical oversight and advertising.